Dual Functioned Hexapeptide‐Coated Lipid‐Core Nanomicelles Suppress Toll‐Like Receptor‐Mediated Inflammatory Responses through Endotoxin Scavenging and Endosomal pH Modulation
Open Access
- 20 April 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (19) , e2301230
Abstract
Excessive activation of Toll‐like receptor (TLR) signaling pathways and the circulating endotoxin are key players in the pathogenesis of many acute and chronic inflammatory diseases. Regulation of TLR‐mediated inflammatory responses by bioactive nanodevices represents a promising strategy for treating these diseases. In searching for novel, clinically applicable nanodevices with potent TLR inhibitory activities, three types of hexapeptide‐modified nano‐hybrids with different cores of phospholipid nanomicelles, liposomes, and poly(lactic‐co‐glycolic acid) nanoparticles are constructed. Interestingly, only the peptide‐modified lipid–core nanomicelles (M‐P12) display potent TLR inhibitory activities. Further mechanistic studies disclose that lipid–core nanomicelles have a generic property to bind to and scavenge lipophilic TLR ligands including lipopolysaccharide to block the ligand–receptor interaction and down‐regulate the TLR signaling extracellularly. In addition, the peptide modification enables M‐P12 a unique capability to modulate endosomal acidification upon being endocytosed into macrophages, which subsequently regulates the endosomal TLR signal transduction. In an acute lung injury mouse model, intratracheal administration of M‐P12 can effectively target lung macrophages and reduce lung inflammation and injuries. This work defines a dual mechanism of action of the peptide‐modified lipid–core nanomicelles in regulating TLR signaling, and provides new strategies for the development of therapeutic nanodevices for treating inflammatory diseases.Keywords
Funding Information
- National Natural Science Foundation of China (82270096, 81971549)
- Natural Science Foundation of Tianjin Municipal Science and Technology Commission (20JCYBJC00040)
This publication has 62 references indexed in Scilit:
- Recognition of lipid A variants by the TLR4-MD-2 receptor complexFrontiers in Cellular and Infection Microbiology, 2013
- Dissecting negative regulation of Toll-like receptor signalingTrends in Immunology, 2012
- Pattern Recognition Receptors and InflammationCell, 2010
- Endosomes: A legitimate platform for the signaling trainProceedings of the National Academy of Sciences, 2009
- pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 SignalingJournal of Biological Chemistry, 2009
- Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis modelBritish Journal of Pharmacology, 2009
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal TumorsGastroenterology, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004